Navigation Links
Experts Identify Vaccine Target for HIV

which keeps the immune system from recognizing the virus as foreign. HLA-C however is not thought to be turned off by HIV-1. The new results suggest that for some individuals at least HLA-C is involved in controlling HIV-1. Since HIV-1 appears unable to shut off HLA-C, unlike A and B, HLA-C may represent an Achilles heel of HIV, according to Goldstein, who said that a vaccine could be designed to elicit an HLA-C mediated response which HIV-1 might be unable to defuse.

This study was the first time a genome-wide approach has been used for an infectious disease. Past studies have looked at individual candidate genes. Since different people respond differently to infections, a better understanding of how immune system genes control responses to infections should help us to design better treatments and more effective vaccines, Goldstein said.

CHAVI was designed to do big science, and the results of this analysis represent just the first of what should be many advances. The technology used and collaborative efforts involved were truly remarkable: together as a group we were able to do something that none of us individually could accomplish. The results of this and future CHAVI studies should help individual laboratories across the world perform research to better understand the virus, lead researcher, Barton Haynes, M.D said.

When someone becomes infected with HIV, the amount of virus in the blood spikes as the virus multiplies. After this peak, the amount of virus in the blood, known as the viral load, gradually decreases and then levels off, a period during which patients do not exhibit symptoms of their disease. The viral load during this levelling out is an indication of how well the patients own immune system is battling the virus, and this is the point in the infections natural history that the researchers studied.

The CHAVI investigators wanted to study those patients who had many sequential blood samples tak
'"/>




Page: 1 2 3

Related medicine news :

1. Good carb, bad carb? Experts debate.
2. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Experts Insist That Neonatal Herpes Be Reported Regularly
5. Experts State Strategies To Increase Good Cholesterol
6. Cancer Can Recur Any Time, Experts Caution
7. Experts Building Bird Flu Warning System
8. Human Growth Hormone (HGH) - View of Experts
9. Experts urging artery screening in the UK
10. Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims
11. Birds Being Shot Owing To Bird Flu Fear: Wildlife Experts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experts Identify Vaccine Target for HIV

(Date:5/15/2008)...ural organic atoms with metal complexes, scientist...e of enzyme inhibitor capable of blocking a bioche...lopment. , Based on studies in human melanoma c...w ways to treat cancer by dampening the overactive...growth. , Details of the study, to be published ...
(Date:5/15/2008)...audit of community hospitals associated with Fox C... partnership between a major academic cancer cente... and community hospitals, where most care is provi...ffectively disseminating advances in cancer treatm...ive Cancer Center in Philadelphia, first establish...
(Date:5/15/2008)...he anti-inflammatory medication also known by the ...uces a specific proliferation measurement of preca...from The University of Texas M. D. Anderson Cancer...e of COX-2 inhibition toward preventing lung cance...disease. , The study is the first large randomiz...
(Date:5/15/2008)...re/ -- JumpStart Inc., the Northeast Ohio,venture ...th of innovative,early-stage businesses and ideas,...0 in CerviLenz(TM), Inc. The Cleveland-based compa...inistration cleared medical,device that allows obs...egnant women, which has been established by the Na...
Breaking Medicine News(10 mins):Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3
...rom Georgia Institute of Technology, US and the Jo...h the pathogenic bacteria defends itself from the ...ave reported the results of their research in the ... cause food borne illness by producing toxins in t...
...om Asan medical center has reported in the Journal...ffective in treating emotional stress or emotional...earchers conducted their study in 152 patients who...months and the results found that the study patien...
...nts with breast cancer and adversely affects the l...ished in the January 15 issue of the American Jour...om a Chinese study are identical to conclusions th...udies and ponit to the fact that obesity seems to ...
...jected alarming results that the practice of inter... the risk of contracting HIV virus by a margin of ...ased risk if detergents are used for the same acco...esults of this research can be found in Aids journ...
Other Medicine News:Health News:Increased Risk Of HIV Transmission Following Vaginal Washing 2
(Date:5/15/2008)...SAN FRANCISCO, May 15 /- Me...at data from an ongoing Phase 1-2 clinical,trial o... will be presented,in an oral presentation at the ...Annual Meeting in Chicago., Session title: New ...cer Session date and time: Monday, June 2 at 11:3...
(Date:5/15/2008)...ase II Data Presented at ASCO Showed Acceptable To... of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J...otherapeutic agent eribulin mesylate (E7389) demon...n of women with locally advanced or metastatic,bre... Phase II clinical,trial. The study also suggests ...
(Date:5/15/2008)...KENILWORTH, N.J., May 15 /-...er in advancing the science and treatment of,chron...day that data from,several clinical studies with P...) (ribavirin, USP) combination therapy, as well as...V protease inhibitor, will be presented at,the 39t...
(Date:5/15/2008)...xcellent results obtained with a newly cleared dev...plaques of interest that are associated with ...BURLINGTON, Mass., May 15 /- InfraReD...t Hospital in Royal Oak, Mich., have,successfully ... patient,undergoing a cardiac catheterization. Thi...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Transportation 3A Making Connections Event to Explore Opportunities and Solutions for People With Disabilities 18695 1Transportation 3A Making Connections Event to Explore Opportunities and Solutions for People With Disabilities 18695 2Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 18692 1Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 18692 2Vail Valley Medical Center Board of Directors Announces Appointment of New President 26 CEO John Cassin 18689 1Vail Valley Medical Center Board of Directors Announces Appointment of New President 26 CEO John Cassin 18689 2Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 1Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 2Electronic Pillbox Helps Seniors Stick to Drug Regimens 18686 3
...ed 11 Percent Fewer RA Patients,Reported Job Loss ...red to Methotrexate Alone, BARCELONA, Spain, June ...ritis (RA) is one of the most common causes of,dis...day show that,rheumatoid arthritis (RA) patients t... working longer, had fewer absences and reported,g...
...007 /PRNewswire-FirstCall/ --,Genzyme Corp. today ... a powder form of Renvela (sevelamer carbonate) to...ing one trial in which,patients received the powde...s administered once per day. , Genzyme is developi... option for patients with chronic kidney disease i...
Other Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 2Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 3Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 4Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 5
Disposable bars made of silver/silver chloride have contacts spaced three centimeters center-tocenter. Also perforated for easy separation into two individual tabs. For use with mini-crocodile clip l
Our SurgiCool surgeon cooling system has been developed utilizing all the expertise gained in high performance motorsports. Our cool suit is simple to use and provides powerful cooling from ice water
Wrap-around, silver/silver chloride ring electrodes fit pediatric to adult patients. For use with minicrocodile clip lead wires (page 17). Dimensions: 10 cm (4 in) long, 0.6 cm (0.25 in) wide. Each 1
... Precision PCx point of care blood glucose monitor...system for healthcare professionals. Ergonomic and...esults. Automatic upload of results to hospital an...data management capabilities.,The Precision P...
Medicine Products: